Postmenopausal hormone therapy and cardiovascular disease: One view of the elephant

Menopause

Volumn 12, Issue 4, 2005, Pages 357-358

  Speroff, Leon ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ARTERY INTIMA; ARTERY MEDIA; ATHEROSCLEROSIS; BODY MASS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; EDITORIAL; ESTROGEN THERAPY; FOLLOW UP; HEART INFARCTION; HORMONAL THERAPY; HUMAN; INSULIN RESISTANCE; INTIMA MEDIA THICKNESS; ISCHEMIC HEART DISEASE; POSTMENOPAUSE; PRIMARY PREVENTION;

AGE FACTORS; CORONARY DISEASE; DATA INTERPRETATION, STATISTICAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS;

EID: 23244463901     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000165269.97121.83     Document Type: Editorial

References (10)

1. Bush TL. The not so randomized clinical trial. Int J Fertil 2001;46:56-59.
2. Hodis HN, Mack WJ, Lobo RA, et al. Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;135:939-953.
3. Karim R, Mack WJ, Lobo RA, et al. Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial. Menopause 2005;12:366-373.
4. Mack WJ, Hameed AB, Xiang M, et al. Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the Estrogen in the Prevention of Atherosclerosis Trial. Atherosclerosis 2003;168:91-98.
5. De Kleijn MJ, Bots ML, Bak AA, et al. Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness. Maturitas 1999;32:195-204.
6. Angerer P, Störk S, Kothny W, Schmitt P, Von Schacky C. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis. A randomized, controlled trial. Atheroscler Thromb Vasc Biol 2001;21:262-268.
7. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-534.
8. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
9. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomized Controlled Trial. JAMA 2004;291:1707-1712.
10. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-1854.